Understanding the absence of renewable electricity imports to the European Union

被引:12
|
作者
Lilliestam, Johan [1 ]
Ellenbeck, Saskia [2 ]
Karakosta, Charikleia [3 ]
Caldes, Natalia [4 ]
机构
[1] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Environm Syst Sci, Climate Policy Grp, Zurich, Switzerland
[2] PIK, Potsdam Inst Climate Impact Res, Dept Transdisciplinary Concepts & Methods, SuperSmart Grid Res Grp, Potsdam, Germany
[3] Natl Tech Univ Athens, Management & Decis Support Syst Lab, Energy Policy Unit, Athens, Greece
[4] CIEMAT, Dept Energy, Energy Syst Anal Unit, Madrid, Spain
基金
欧洲研究理事会;
关键词
Acceptance; Stakeholder meetings; Exports; Imports; Literature analysis; Article; 9; Cooperation mechanism; Renewable electricity;
D O I
10.1108/IJESM-10-2014-0002
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Purpose - This paper aims to analyse reasons for the absence of renewable electricity (RE) imports to the European Union, for which the authors develop a multi-level heuristic. Design/methodology/approach - The heuristic covers three sequential acceptance levels: political attractiveness (macro-level), the "business case" (micro-level) and civil society perspectives (public discourse level). Findings - Numerous factors on all three levels determine the success/demise of renewables trade. So far, trade has failed on the macro-level, because European policymakers perceive that targets can be achieved domestically with significant co-benefits and because exporter countries have rapidly increasing electricity demand, limiting the realisable exports. As policymakers deemed it unattractive, they have not implemented policy-supported business cases. Public opposition against trade has not been an issue as no concrete plans or projects have been proposed. Research limitations/implications - The authors show that the factors determining whether a RE programme is successful are plentiful and extend far beyond potential cost savings. This suggests that future research and the energy policy debate should better account for how cost savings are weighed against other policy aims and explicitly include the perspectives of investors and the public. Originality/value - This paper adds the first holistic analysis of success/failure factors for RE trade to Europe. The three-level, sequential framework is new to energy policy analysis.
引用
收藏
页码:291 / 311
页数:21
相关论文
共 50 条
  • [1] Vulnerability to terrorist attacks in European electricity decarbonisation scenarios: Comparing renewable electricity imports to gas imports
    Lilliestam, Johan
    ENERGY POLICY, 2014, 66 : 234 - 248
  • [2] Towards renewable electricity in Europe: Revisiting the determinants of renewable electricity in the European Union
    Domhnaill, Ciaran Mac
    Ryan, Lisa
    RENEWABLE ENERGY, 2020, 154 (154) : 955 - 965
  • [4] RELIANCE ON RUSSIAN FEDERATION ENERGY IMPORTS AND RENEWABLE ENERGY IN THE EUROPEAN UNION
    Ilie, Anca Gabriela
    Luminita Emanuela Zlatea, Marinela
    Negreanu, Cristina
    Dumitriu, Dan
    Pentescu, Alma
    AMFITEATRU ECONOMIC, 2023, 25 (64) : 780 - 797
  • [5] Harmonization of renewable electricity feed-in laws in the European Union
    Munoz, Miquel
    Oschmann, Volker
    Tabara, J. David
    ENERGY POLICY, 2007, 35 (05) : 3104 - 3114
  • [6] Support schemes for renewable electricity in the European Union: Producer strategies and competition
    Dressler, Luisa
    ENERGY ECONOMICS, 2016, 60 : 186 - 196
  • [7] Renewable energies (green electricity) in the European Union's case law
    Delgado Piqueras, Francisco
    ACTUALIDAD JURIDICA AMBIENTAL, 2020, (102): : 140 - 174
  • [8] Renewable Energy in the Electricity Sector and GDP per Capita in the European Union
    Simionescu, Mihaela
    Bilan, Yuriy
    Krajnakova, Emilia
    Streimikiene, Dalia
    Gedek, Stanislaw
    ENERGIES, 2019, 12 (13)
  • [9] Parallel imports of pharmaceuticals in the European Union
    Darba, J
    Rovira, J
    PHARMACOECONOMICS, 1998, 14 (Suppl 1) : 129 - 136
  • [10] Parallel Imports of Pharmaceuticals in the European Union
    Josep Darbà
    Joan Rovira
    PharmacoEconomics, 1998, 14 : 129 - 136